Zobrazeno 1 - 10
of 47
pro vyhledávání: '"J W, Sweetenham"'
Autor:
Roy B. Jones, Peter A. McSweeney, Jonathan A. Gutman, J. W. Sweetenham, Chan Zeng, Anna E. Barón, Y. Nieto, Elizabeth J. Shpall, Scott I. Bearman
Publikováno v:
Bone Marrow Transplantation. 36:443-451
We report outcomes in advanced lymphoma patients (n = 32) who enrolled in a trial of prospectively planned combined autologous/reduced-intensity transplantation (RIT) (n = 25) or who received RIT shortly after prior autografting because of high relap
Publikováno v:
European Journal of Cancer. 39:335-345
Health-related quality of life (HrQOL) assessments are gaining importance as outcome measures in cancer clinical trials. A recently published clinical trial reported statistically significant (P0.001) increases in haemoglobin (Hb) levels and signific
Publikováno v:
British Journal of Haematology. 100:112-122
We used flow cytometry to characterize cell adhesion molecule expression of the human haemopoietic cell lines KG1a, K562, HL-60, NALM-6 and CEM. A 51chromium labelling assay was used to study the adhesion of these cell lines to extracellular matrix c
Publikováno v:
Hematology. 1:177-181
Publikováno v:
Annals of Oncology. 4:857-860
Summary Background Patients with advanced Hodgkin's disease failing to achieve complete remission with chemotherapy or developing disease progression within 1 year have a poor prognosis with salvage chemotherapy. Patients and methods Twenty-five pati
Autor:
J. W. Sweetenham
Publikováno v:
Current hematologic malignancy reports. 1(4)
Lymphoblastic lymphoma (LBL) accounts for approximately 4% of all adult patients with non-Hodgkin’s lymphoma (NHL). It is recognised as a distinct clinopathological entity in all of the recently described classifications for NHL, including the Revi
Autor:
J. W. Sweetenham
Publikováno v:
British Journal of Cancer. 82:4-6
Publikováno v:
Journal of Clinical Oncology. 9:2202-2209
High response and overall survival rates have been reported for second- and third-generation combination chemotherapy regimens used in the treatment of advanced intermediate- and high-grade non-Hodgkin's lymphoma (NHL). Results with methotrexate with
Publikováno v:
British Journal of Cancer
Retrospective studies have recently demonstrated a significant correlation between dose intensity of chemotherapy and response rates and survival in various diseases including epithelial ovarian carcinoma. As part of a proposed randomised trial to as
Publikováno v:
European Journal of Cancer. 29:190-192
27 patients with relapsed/refractory non-Hodgkin lymphoma (NHL) received combination chemotherapy with prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET). 25 patients are evaluable for response. 7 (26%) obtained a